Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy.
Rasing M, van Son M, Moerland M, de Keizer B, Wessels F, Jonges T, van de Pol S, Eppinga W, Noteboom J, Lagendijk J, van der Voort van Zijp J, Peters M. Rasing M, et al. Among authors: van de pol s. Cancers (Basel). 2022 Feb 3;14(3):781. doi: 10.3390/cancers14030781. Cancers (Basel). 2022. PMID: 35159048 Free PMC article.
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Among authors: van de pol s, van vulpen m, van der voort van zyp j. Radiother Oncol. 2015 Nov;117(2):262-9. doi: 10.1016/j.radonc.2015.08.018. Epub 2015 Sep 5. Radiother Oncol. 2015. PMID: 26349590
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Brachytherapy. 2016 Jan-Feb;15(1):85-93. doi: 10.1016/j.brachy.2015.10.004. Epub 2015 Nov 21. Brachytherapy. 2016. PMID: 26614233
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.
Peters M, van der Voort van Zyp JR, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PS, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Among authors: van rossum ps, van de pol s, van der voort van zyp jr, van vulpen m. Radiother Oncol. 2016 Apr;119(1):104-10. doi: 10.1016/j.radonc.2016.02.002. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897512 Free article.
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
Peters M, van der Voort van Zyp JRN, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PSN, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Among authors: van der voort van zyp jrn, van de pol s, van vulpen m, van rossum psn. Brachytherapy. 2016 May-Jun;15(3):296-305. doi: 10.1016/j.brachy.2016.01.004. Epub 2016 Mar 2. Brachytherapy. 2016. PMID: 26948662
Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for 125I prostate brachytherapy.
Peters M, Smit Duijzentkunst DA, Westendorp H, van de Pol SMG, Kattevilder R, Schellekens A, van der Voort van Zyp JRN, Moerland MA, van Vulpen M, Hoekstra CJ. Peters M, et al. Among authors: van der voort van zyp jrn, van vulpen m, van de pol smg. Brachytherapy. 2017 Mar-Apr;16(2):282-290. doi: 10.1016/j.brachy.2016.11.018. Epub 2017 Jan 16. Brachytherapy. 2017. PMID: 28110899
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients.
van Son M, Peters M, Moerland M, van de Pol S, Eppinga W, Lagendijk J, van der Voort van Zyp J. van Son M, et al. Among authors: van de pol s. Clin Transl Radiat Oncol. 2020 Dec 11;27:1-7. doi: 10.1016/j.ctro.2020.12.002. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2020. PMID: 33364450 Free PMC article.
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
Willigenburg T, van Son MJ, van de Pol SMG, Eppinga WSC, Lagendijk JJW, de Boer HCJ, Moerland MA, van der Voort van Zyp JRN, Peters M. Willigenburg T, et al. Among authors: van de pol smg. Clin Transl Radiat Oncol. 2021 Jun 29;30:7-14. doi: 10.1016/j.ctro.2021.06.005. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34278009 Free PMC article.
16 results